CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
7.54
-0.60 (-7.37%)
At close: Aug 14, 2026, 4:00 PM EDT
7.59
+0.05 (0.68%)
After-hours: Aug 14, 2026, 5:43 PM EDT
CorMedix Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 462.25 | 311.71 | 43.47 | - | 0.07 | 0.19 | |
Revenue Growth | 280.50% | 617.03% | - | - | -65.74% | -20.19% |
Cost of Revenue | 45.24 | 22.09 | 3.03 | - | 0 | 0.15 |
Gross Profit | 417.01 | 289.62 | 40.44 | - | 0.06 | 0.04 |
Selling, General & Admin | 127.8 | 96.07 | 58.7 | 35.8 | 20.01 | 16.35 |
Research & Development | 27.59 | 19.33 | 3.94 | 13.16 | 10.68 | 13.13 |
Amortization of Goodwill & Intangibles | 34.37 | 13.87 | 0.16 | - | - | - |
Operating Expenses | 189.77 | 129.28 | 62.79 | 48.96 | 30.69 | 29.48 |
Operating Income | 227.24 | 160.34 | -22.36 | -48.96 | -30.62 | -29.44 |
Interest Expense | -2.78 | -2.78 | -0.04 | -0.03 | -0.03 | -0.02 |
Interest & Investment Income | 3.85 | 3.85 | 2.58 | 2.68 | 0.33 | 0.01 |
Currency Exchange Gain (Loss) | -0.05 | -0.05 | -0.03 | -0.03 | 0.04 | -0.02 |
Other Non Operating Income (Expenses) | -1.66 | - | 0.52 | - | - | - |
EBT Excluding Unusual Items | 226.59 | 161.35 | -19.33 | -46.34 | -30.29 | -29.46 |
Merger & Restructuring Charges | -10.2 | -10.2 | - | - | - | - |
Gain (Loss) on Sale of Investments | 4.36 | 5.36 | - | - | - | - |
Other Unusual Items | -17.35 | -6.5 | - | - | - | - |
Pretax Income | 203.4 | 150.02 | -19.33 | -46.34 | -30.29 | -29.46 |
Income Tax Expense | 16.23 | -13.04 | -1.4 | - | -0.59 | -1.25 |
Net Income | 187.17 | 163.06 | -17.93 | -46.34 | -29.7 | -28.21 |
Preferred Dividends & Other Adjustments | 1.16 | 0.99 | - | - | - | - |
Net Income to Common | 186.02 | 162.07 | -17.93 | -46.34 | -29.7 | -28.21 |
Net Income Growth | 265.29% | - | - | - | - | - |
Shares Outstanding (Basic) | 78 | 72 | 59 | 51 | 40 | 38 |
Shares Outstanding (Diluted) | 91 | 80 | 59 | 51 | 40 | 38 |
Shares Change | 40.04% | 36.41% | 15.65% | 26.39% | 6.93% | 31.87% |
EPS (Basic) | 2.38 | 2.25 | -0.30 | -0.91 | -0.74 | -0.75 |
EPS (Diluted) | 2.08 | 2.04 | -0.30 | -0.91 | -0.74 | -0.75 |
EPS Growth | 163.53% | - | - | - | - | - |
Free Cash Flow | 250.42 | 172.79 | -50.73 | -38.74 | -24.58 | -22.58 |
Free Cash Flow Per Share | 2.74 | 2.15 | -0.86 | -0.76 | -0.61 | -0.60 |
Gross Margin | 90.21% | 92.91% | 93.02% | - | 94.29% | 22.00% |
Operating Margin | 49.16% | 51.44% | -51.43% | - | -46819.91% | -15417.51% |
Profit Margin | 40.24% | 51.99% | -41.24% | - | -45409.90% | -14774.70% |
Free Cash Flow Margin | 54.17% | 55.43% | -116.70% | - | -37573.53% | -11826.24% |
EBITDA | 262.55 | 174.89 | -22.05 | -48.89 | -30.54 | -29.38 |
EBITDA Margin | 56.80% | 56.11% | -50.71% | - | - | - |
D&A For EBITDA | 35.31 | 14.55 | 0.31 | 0.07 | 0.08 | 0.06 |
EBIT | 227.24 | 160.34 | -22.36 | -48.96 | -30.62 | -29.44 |
EBIT Margin | 49.16% | 51.44% | -51.43% | - | - | - |
Revenue as Reported | 462.25 | 311.71 | 43.47 | - | - | - |